Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 December, 2017 04:31 IST
Glenmark Pharma secures USFDA nod for Clobetasol Propionate ointment
Source: IRIS | 21 Mar, 2017, 09.44AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Ointment USP, 0.05%, the generic version of Temovate Ointment, 0.05% of Fougera Pharmaceuticals Inc.

According to IMS Health sales data for the 12 month period ending January 2017, the Temovate Ointment, 0.05% market1 achieved annual sales of approximately USD 175.3 million.

Glenmark's current portfolio consists of 113 products authorized for distribution in the U.S. marketplace and approximately 64 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark (Q,N,C,F)* continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Shares of the company gained Rs 0.9, or 0.1%, to trade at Rs 881.25. The total volume of shares traded was 6,211 at the BSE (9.35 a.m., Tuesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Tata Motors to increase prices of passenger vehicles by 25K - 11-Dec-2017 13:30
Parag Milk Foods joins hands with Taj Group - 11-Dec-2017 13:25
Suven Life Sciences secures product patents in India & USA - 11-Dec-2017 11:08
Alembic Pharma's arm gets fast track designation for RP6530 - 11-Dec-2017 11:05
Sadbhav Infrastructure signs contract worth Rs 1.50 bn - 11-Dec-2017 10:57
IL&FS Engineering bags order worth Rs 2.15 bn - 11-Dec-2017 10:33
Raminfo bags contract from Rajcom Info Services - 11-Dec-2017 10:25
Glenmark Pharma starts trial of investigational immuno-oncology agent GBR 1342 - 08-Dec-2017 10:45
TVS Motor acquires 14.78% stake in Ultraviolette Automotive - 08-Dec-2017 10:18
Emami to acquire 30% stake in Helios Lifestyle - 08-Dec-2017 10:04
Cyient enters into global alliance with EA Tech - 07-Dec-2017 15:35
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer